aluates Reports

$ 0.0

Automative

Tissue Sealing Agents and Hemostasis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-7R7895

Global Tissue Sealing Agents and Hemostasis Market Insights Forecast to 2028

BUY CHAPTERS

Tissue Sealing Agents and Hemostasis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-7R7895

Report

October 2024

Pages:98

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Advanced Medical Solutions Group plc

Baxter

Cohera Medical Inc

CryoLife

C R Bard Inc

Johnson & Johnson Services Inc.

Integra LifeSciences Corporation

Pfizer Inc

Tissue Sealing Agents and Hemostasis - Market Size

The global market for Tissue Sealing Agents and Hemostasis was estimated to be worth US$ 3559.5 million in 2023 and is forecast to a readjusted size of US$ 4427.5 million by 2030 with a CAGR of 3.1% during the forecast period 2024-2030

Tissue Sealing Agents and Hemostasis - Market

Hemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing.

Tissue sealing agents are used during medical procedures to achieve hemostasis. They vary based on their mechanism of action, composition, ease of application, adherence to tissue, immunogenicity and cost. These agents permit rapid hemostasis, better Visualization of the surgical area, shorter operative times, decreased requirement for transfusions, decreased wound healing time and overall improvement in patient recovery time.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tissue Sealing Agents and Hemostasis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Tissue Sealing Agents and Hemostasis by region & country, by Type, and by Application.

The Tissue Sealing Agents and Hemostasis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tissue Sealing Agents and Hemostasis.

Market Segmentation

Scope of Tissue Sealing Agents and Hemostasis - Market Report

Report Metric	Details
Report Name	Tissue Sealing Agents and Hemostasis - Market
Forecasted market size in 2030	US$ 4427.5 million
CAGR	3.1%
Forecasted years	2024 - 2030
Segment by Type:	Natural Tissue Sealants Synthetic Tissue Sealants Others
Segment by Application	Academics Hospitals Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Advanced Medical Solutions Group plc, Baxter, Cohera Medical, Inc., CryoLife, Inc., C.R. Bard, Inc., Johnson & Johnson Services, Inc., Integra LifeSciences Corporation, Pfizer, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Tissue Sealing Agents and Hemostasis manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Tissue Sealing Agents and Hemostasis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Tissue Sealing Agents and Hemostasis in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Tissue Sealing Agents and Hemostasis - Market size in 2030?

Ans: The Tissue Sealing Agents and Hemostasis - Market size in 2030 will be US$ 4427.5 million.

Who are the main players in the Tissue Sealing Agents and Hemostasis - Market report?

Ans: The main players in the Tissue Sealing Agents and Hemostasis - Market are Advanced Medical Solutions Group plc, Baxter, Cohera Medical, Inc., CryoLife, Inc., C.R. Bard, Inc., Johnson & Johnson Services, Inc., Integra LifeSciences Corporation, Pfizer, Inc.

What are the Application segmentation covered in the Tissue Sealing Agents and Hemostasis - Market report?

Ans: The Applications covered in the Tissue Sealing Agents and Hemostasis - Market report are Academics, Hospitals, Laboratories, Others

What are the Type segmentation covered in the Tissue Sealing Agents and Hemostasis - Market report?

Ans: The Types covered in the Tissue Sealing Agents and Hemostasis - Market report are Natural Tissue Sealants, Synthetic Tissue Sealants, Others

Recommended Reports

Hemostatic Agents

Surgical Sealants

Absorbable Solutions

1 Market Overview

1.1 Tissue Sealing Agents and Hemostasis Product Introduction

1.2 Global Tissue Sealing Agents and Hemostasis Market Size Forecast

1.3 Tissue Sealing Agents and Hemostasis Market Trends & Drivers

1.3.1 Tissue Sealing Agents and Hemostasis Industry Trends

1.3.2 Tissue Sealing Agents and Hemostasis Market Drivers & Opportunity

1.3.3 Tissue Sealing Agents and Hemostasis Market Challenges

1.3.4 Tissue Sealing Agents and Hemostasis Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Tissue Sealing Agents and Hemostasis Players Revenue Ranking (2023)

2.2 Global Tissue Sealing Agents and Hemostasis Revenue by Company (2019-2024)

2.3 Key Companies Tissue Sealing Agents and Hemostasis Manufacturing Base Distribution and Headquarters

2.4 Key Companies Tissue Sealing Agents and Hemostasis Product Offered

2.5 Key Companies Time to Begin Mass Production of Tissue Sealing Agents and Hemostasis

2.6 Tissue Sealing Agents and Hemostasis Market Competitive Analysis

2.6.1 Tissue Sealing Agents and Hemostasis Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Tissue Sealing Agents and Hemostasis Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tissue Sealing Agents and Hemostasis as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Natural Tissue Sealants

3.1.2 Synthetic Tissue Sealants

3.1.3 Others

3.2 Global Tissue Sealing Agents and Hemostasis Sales Value by Type

3.2.1 Global Tissue Sealing Agents and Hemostasis Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Tissue Sealing Agents and Hemostasis Sales Value, by Type (2019-2030)

3.2.3 Global Tissue Sealing Agents and Hemostasis Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Academics

4.1.2 Hospitals

4.1.3 Laboratories

4.1.4 Others

4.2 Global Tissue Sealing Agents and Hemostasis Sales Value by Application

4.2.1 Global Tissue Sealing Agents and Hemostasis Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Tissue Sealing Agents and Hemostasis Sales Value, by Application (2019-2030)

4.2.3 Global Tissue Sealing Agents and Hemostasis Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Tissue Sealing Agents and Hemostasis Sales Value by Region

5.1.1 Global Tissue Sealing Agents and Hemostasis Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Tissue Sealing Agents and Hemostasis Sales Value by Region (2019-2024)

5.1.3 Global Tissue Sealing Agents and Hemostasis Sales Value by Region (2025-2030)

5.1.4 Global Tissue Sealing Agents and Hemostasis Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Tissue Sealing Agents and Hemostasis Sales Value, 2019-2030

5.2.2 North America Tissue Sealing Agents and Hemostasis Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Tissue Sealing Agents and Hemostasis Sales Value, 2019-2030

5.3.2 Europe Tissue Sealing Agents and Hemostasis Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Tissue Sealing Agents and Hemostasis Sales Value, 2019-2030

5.4.2 Asia Pacific Tissue Sealing Agents and Hemostasis Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Tissue Sealing Agents and Hemostasis Sales Value, 2019-2030

5.5.2 South America Tissue Sealing Agents and Hemostasis Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Tissue Sealing Agents and Hemostasis Sales Value, 2019-2030

5.6.2 Middle East & Africa Tissue Sealing Agents and Hemostasis Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Tissue Sealing Agents and Hemostasis Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Tissue Sealing Agents and Hemostasis Sales Value

6.3 United States

6.3.1 United States Tissue Sealing Agents and Hemostasis Sales Value, 2019-2030

6.3.2 United States Tissue Sealing Agents and Hemostasis Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Tissue Sealing Agents and Hemostasis Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Tissue Sealing Agents and Hemostasis Sales Value, 2019-2030

6.4.2 Europe Tissue Sealing Agents and Hemostasis Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Tissue Sealing Agents and Hemostasis Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Tissue Sealing Agents and Hemostasis Sales Value, 2019-2030

6.5.2 China Tissue Sealing Agents and Hemostasis Sales Value by Type (%), 2023 VS 2030

6.5.3 China Tissue Sealing Agents and Hemostasis Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Tissue Sealing Agents and Hemostasis Sales Value, 2019-2030

6.6.2 Japan Tissue Sealing Agents and Hemostasis Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Tissue Sealing Agents and Hemostasis Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Tissue Sealing Agents and Hemostasis Sales Value, 2019-2030

6.7.2 South Korea Tissue Sealing Agents and Hemostasis Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Tissue Sealing Agents and Hemostasis Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Tissue Sealing Agents and Hemostasis Sales Value, 2019-2030

6.8.2 Southeast Asia Tissue Sealing Agents and Hemostasis Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Tissue Sealing Agents and Hemostasis Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Tissue Sealing Agents and Hemostasis Sales Value, 2019-2030

6.9.2 India Tissue Sealing Agents and Hemostasis Sales Value by Type (%), 2023 VS 2030

6.9.3 India Tissue Sealing Agents and Hemostasis Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Advanced Medical Solutions Group plc

7.1.1 Advanced Medical Solutions Group plc Profile

7.1.2 Advanced Medical Solutions Group plc Main Business

7.1.3 Advanced Medical Solutions Group plc Tissue Sealing Agents and Hemostasis Products, Services and Solutions

7.1.4 Advanced Medical Solutions Group plc Tissue Sealing Agents and Hemostasis Revenue (US$ Million) & (2019-2024)

7.1.5 Advanced Medical Solutions Group plc Recent Developments

7.2 Baxter

7.2.1 Baxter Profile

7.2.2 Baxter Main Business

7.2.3 Baxter Tissue Sealing Agents and Hemostasis Products, Services and Solutions

7.2.4 Baxter Tissue Sealing Agents and Hemostasis Revenue (US$ Million) & (2019-2024)

7.2.5 Baxter Recent Developments

7.3 Cohera Medical, Inc.

7.3.1 Cohera Medical, Inc. Profile

7.3.2 Cohera Medical, Inc. Main Business

7.3.3 Cohera Medical, Inc. Tissue Sealing Agents and Hemostasis Products, Services and Solutions

7.3.4 Cohera Medical, Inc. Tissue Sealing Agents and Hemostasis Revenue (US$ Million) & (2019-2024)

7.3.5 CryoLife, Inc. Recent Developments

7.4 CryoLife, Inc.

7.4.1 CryoLife, Inc. Profile

7.4.2 CryoLife, Inc. Main Business

7.4.3 CryoLife, Inc. Tissue Sealing Agents and Hemostasis Products, Services and Solutions

7.4.4 CryoLife, Inc. Tissue Sealing Agents and Hemostasis Revenue (US$ Million) & (2019-2024)

7.4.5 CryoLife, Inc. Recent Developments

7.5 C.R. Bard, Inc.

7.5.1 C.R. Bard, Inc. Profile

7.5.2 C.R. Bard, Inc. Main Business

7.5.3 C.R. Bard, Inc. Tissue Sealing Agents and Hemostasis Products, Services and Solutions

7.5.4 C.R. Bard, Inc. Tissue Sealing Agents and Hemostasis Revenue (US$ Million) & (2019-2024)

7.5.5 C.R. Bard, Inc. Recent Developments

7.6 Johnson & Johnson Services, Inc.

7.6.1 Johnson & Johnson Services, Inc. Profile

7.6.2 Johnson & Johnson Services, Inc. Main Business

7.6.3 Johnson & Johnson Services, Inc. Tissue Sealing Agents and Hemostasis Products, Services and Solutions

7.6.4 Johnson & Johnson Services, Inc. Tissue Sealing Agents and Hemostasis Revenue (US$ Million) & (2019-2024)

7.6.5 Johnson & Johnson Services, Inc. Recent Developments

7.7 Integra LifeSciences Corporation

7.7.1 Integra LifeSciences Corporation Profile

7.7.2 Integra LifeSciences Corporation Main Business

7.7.3 Integra LifeSciences Corporation Tissue Sealing Agents and Hemostasis Products, Services and Solutions

7.7.4 Integra LifeSciences Corporation Tissue Sealing Agents and Hemostasis Revenue (US$ Million) & (2019-2024)

7.7.5 Integra LifeSciences Corporation Recent Developments

7.8 Pfizer, Inc.

7.8.1 Pfizer, Inc. Profile

7.8.2 Pfizer, Inc. Main Business

7.8.3 Pfizer, Inc. Tissue Sealing Agents and Hemostasis Products, Services and Solutions

7.8.4 Pfizer, Inc. Tissue Sealing Agents and Hemostasis Revenue (US$ Million) & (2019-2024)

7.8.5 Pfizer, Inc. Recent Developments

8 Industry Chain Analysis

8.1 Tissue Sealing Agents and Hemostasis Industrial Chain

8.2 Tissue Sealing Agents and Hemostasis Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Tissue Sealing Agents and Hemostasis Sales Model

8.5.2 Sales Channel

8.5.3 Tissue Sealing Agents and Hemostasis Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Advanced Medical Solutions Group plc

Baxter

Cohera Medical Inc

CryoLife

C R Bard Inc

Johnson & Johnson Services Inc.

Integra LifeSciences Corporation

Pfizer Inc

List of Tables

Table 1. Tissue Sealing Agents and Hemostasis Market Trends

Table 2. Tissue Sealing Agents and Hemostasis Market Drivers & Opportunity

Table 3. Tissue Sealing Agents and Hemostasis Market Challenges

Table 4. Tissue Sealing Agents and Hemostasis Market Restraints

Table 5. Global Tissue Sealing Agents and Hemostasis Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Tissue Sealing Agents and Hemostasis Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Tissue Sealing Agents and Hemostasis Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Tissue Sealing Agents and Hemostasis Product Type

Table 9. Key Companies Time to Begin Mass Production of Tissue Sealing Agents and Hemostasis

Table 10. Global Tissue Sealing Agents and Hemostasis Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tissue Sealing Agents and Hemostasis as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Tissue Sealing Agents and Hemostasis Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Tissue Sealing Agents and Hemostasis Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Tissue Sealing Agents and Hemostasis Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Tissue Sealing Agents and Hemostasis Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Tissue Sealing Agents and Hemostasis Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Tissue Sealing Agents and Hemostasis Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Tissue Sealing Agents and Hemostasis Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Tissue Sealing Agents and Hemostasis Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Tissue Sealing Agents and Hemostasis Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Tissue Sealing Agents and Hemostasis Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Tissue Sealing Agents and Hemostasis Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Tissue Sealing Agents and Hemostasis Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Tissue Sealing Agents and Hemostasis Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Tissue Sealing Agents and Hemostasis Sales Value by Region (2019-2024) & (%)

Table 27. Global Tissue Sealing Agents and Hemostasis Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Tissue Sealing Agents and Hemostasis Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Tissue Sealing Agents and Hemostasis Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Tissue Sealing Agents and Hemostasis Sales Value, (2025-2030) & (US$ Million)

Table 31. Advanced Medical Solutions Group plc Basic Information List

Table 32. Advanced Medical Solutions Group plc Description and Business Overview

Table 33. Advanced Medical Solutions Group plc Tissue Sealing Agents and Hemostasis Products, Services and Solutions

Table 34. Revenue (US$ Million) in Tissue Sealing Agents and Hemostasis Business of Advanced Medical Solutions Group plc (2019-2024)

Table 35. Advanced Medical Solutions Group plc Recent Developments

Table 36. Baxter Basic Information List

Table 37. Baxter Description and Business Overview

Table 38. Baxter Tissue Sealing Agents and Hemostasis Products, Services and Solutions

Table 39. Revenue (US$ Million) in Tissue Sealing Agents and Hemostasis Business of Baxter (2019-2024)

Table 40. Baxter Recent Developments

Table 41. Cohera Medical, Inc. Basic Information List

Table 42. Cohera Medical, Inc. Description and Business Overview

Table 43. Cohera Medical, Inc. Tissue Sealing Agents and Hemostasis Products, Services and Solutions

Table 44. Revenue (US$ Million) in Tissue Sealing Agents and Hemostasis Business of Cohera Medical, Inc. (2019-2024)

Table 45. Cohera Medical, Inc. Recent Developments

Table 46. CryoLife, Inc. Basic Information List

Table 47. CryoLife, Inc. Description and Business Overview

Table 48. CryoLife, Inc. Tissue Sealing Agents and Hemostasis Products, Services and Solutions

Table 49. Revenue (US$ Million) in Tissue Sealing Agents and Hemostasis Business of CryoLife, Inc. (2019-2024)

Table 50. CryoLife, Inc. Recent Developments

Table 51. C.R. Bard, Inc. Basic Information List

Table 52. C.R. Bard, Inc. Description and Business Overview

Table 53. C.R. Bard, Inc. Tissue Sealing Agents and Hemostasis Products, Services and Solutions

Table 54. Revenue (US$ Million) in Tissue Sealing Agents and Hemostasis Business of C.R. Bard, Inc. (2019-2024)

Table 55. C.R. Bard, Inc. Recent Developments

Table 56. Johnson & Johnson Services, Inc. Basic Information List

Table 57. Johnson & Johnson Services, Inc. Description and Business Overview

Table 58. Johnson & Johnson Services, Inc. Tissue Sealing Agents and Hemostasis Products, Services and Solutions

Table 59. Revenue (US$ Million) in Tissue Sealing Agents and Hemostasis Business of Johnson & Johnson Services, Inc. (2019-2024)

Table 60. Johnson & Johnson Services, Inc. Recent Developments

Table 61. Integra LifeSciences Corporation Basic Information List

Table 62. Integra LifeSciences Corporation Description and Business Overview

Table 63. Integra LifeSciences Corporation Tissue Sealing Agents and Hemostasis Products, Services and Solutions

Table 64. Revenue (US$ Million) in Tissue Sealing Agents and Hemostasis Business of Integra LifeSciences Corporation (2019-2024)

Table 65. Integra LifeSciences Corporation Recent Developments

Table 66. Pfizer, Inc. Basic Information List

Table 67. Pfizer, Inc. Description and Business Overview

Table 68. Pfizer, Inc. Tissue Sealing Agents and Hemostasis Products, Services and Solutions

Table 69. Revenue (US$ Million) in Tissue Sealing Agents and Hemostasis Business of Pfizer, Inc. (2019-2024)

Table 70. Pfizer, Inc. Recent Developments

Table 71. Key Raw Materials Lists

Table 72. Raw Materials Key Suppliers Lists

Table 73. Tissue Sealing Agents and Hemostasis Downstream Customers

Table 74. Tissue Sealing Agents and Hemostasis Distributors List

Table 75. Research Programs/Design for This Report

Table 76. Key Data Information from Secondary Sources

Table 77. Key Data Information from Primary Sources

Table 78. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Tissue Sealing Agents and Hemostasis Product Picture

Figure 2. Global Tissue Sealing Agents and Hemostasis Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Tissue Sealing Agents and Hemostasis Sales Value (2019-2030) & (US$ Million)

Figure 4. Tissue Sealing Agents and Hemostasis Report Years Considered

Figure 5. Global Tissue Sealing Agents and Hemostasis Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Tissue Sealing Agents and Hemostasis Revenue in 2023

Figure 7. Tissue Sealing Agents and Hemostasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Natural Tissue Sealants Picture

Figure 9. Synthetic Tissue Sealants Picture

Figure 10. Others Picture

Figure 11. Global Tissue Sealing Agents and Hemostasis Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 12. Global Tissue Sealing Agents and Hemostasis Sales Value Market Share by Type, 2023 & 2030

Figure 13. Product Picture of Academics

Figure 14. Product Picture of Hospitals

Figure 15. Product Picture of Laboratories

Figure 16. Product Picture of Others

Figure 17. Global Tissue Sealing Agents and Hemostasis Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global Tissue Sealing Agents and Hemostasis Sales Value Market Share by Application, 2023 & 2030

Figure 19. North America Tissue Sealing Agents and Hemostasis Sales Value (2019-2030) & (US$ Million)

Figure 20. North America Tissue Sealing Agents and Hemostasis Sales Value by Country (%), 2023 VS 2030

Figure 21. Europe Tissue Sealing Agents and Hemostasis Sales Value (2019-2030) & (US$ Million)

Figure 22. Europe Tissue Sealing Agents and Hemostasis Sales Value by Country (%), 2023 VS 2030

Figure 23. Asia Pacific Tissue Sealing Agents and Hemostasis Sales Value (2019-2030) & (US$ Million)

Figure 24. Asia Pacific Tissue Sealing Agents and Hemostasis Sales Value by Country (%), 2023 VS 2030

Figure 25. South America Tissue Sealing Agents and Hemostasis Sales Value (2019-2030) & (US$ Million)

Figure 26. South America Tissue Sealing Agents and Hemostasis Sales Value by Country (%), 2023 VS 2030

Figure 27. Middle East & Africa Tissue Sealing Agents and Hemostasis Sales Value (2019-2030) & (US$ Million)

Figure 28. Middle East & Africa Tissue Sealing Agents and Hemostasis Sales Value by Country (%), 2023 VS 2030

Figure 29. Key Countries/Regions Tissue Sealing Agents and Hemostasis Sales Value (%), (2019-2030)

Figure 30. United States Tissue Sealing Agents and Hemostasis Sales Value, (2019-2030) & (US$ Million)

Figure 31. United States Tissue Sealing Agents and Hemostasis Sales Value by Type (%), 2023 VS 2030

Figure 32. United States Tissue Sealing Agents and Hemostasis Sales Value by Application (%), 2023 VS 2030

Figure 33. Europe Tissue Sealing Agents and Hemostasis Sales Value, (2019-2030) & (US$ Million)

Figure 34. Europe Tissue Sealing Agents and Hemostasis Sales Value by Type (%), 2023 VS 2030

Figure 35. Europe Tissue Sealing Agents and Hemostasis Sales Value by Application (%), 2023 VS 2030

Figure 36. China Tissue Sealing Agents and Hemostasis Sales Value, (2019-2030) & (US$ Million)

Figure 37. China Tissue Sealing Agents and Hemostasis Sales Value by Type (%), 2023 VS 2030

Figure 38. China Tissue Sealing Agents and Hemostasis Sales Value by Application (%), 2023 VS 2030

Figure 39. Japan Tissue Sealing Agents and Hemostasis Sales Value, (2019-2030) & (US$ Million)

Figure 40. Japan Tissue Sealing Agents and Hemostasis Sales Value by Type (%), 2023 VS 2030

Figure 41. Japan Tissue Sealing Agents and Hemostasis Sales Value by Application (%), 2023 VS 2030

Figure 42. South Korea Tissue Sealing Agents and Hemostasis Sales Value, (2019-2030) & (US$ Million)

Figure 43. South Korea Tissue Sealing Agents and Hemostasis Sales Value by Type (%), 2023 VS 2030

Figure 44. South Korea Tissue Sealing Agents and Hemostasis Sales Value by Application (%), 2023 VS 2030

Figure 45. Southeast Asia Tissue Sealing Agents and Hemostasis Sales Value, (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Tissue Sealing Agents and Hemostasis Sales Value by Type (%), 2023 VS 2030

Figure 47. Southeast Asia Tissue Sealing Agents and Hemostasis Sales Value by Application (%), 2023 VS 2030

Figure 48. India Tissue Sealing Agents and Hemostasis Sales Value, (2019-2030) & (US$ Million)

Figure 49. India Tissue Sealing Agents and Hemostasis Sales Value by Type (%), 2023 VS 2030

Figure 50. India Tissue Sealing Agents and Hemostasis Sales Value by Application (%), 2023 VS 2030

Figure 51. Tissue Sealing Agents and Hemostasis Industrial Chain

Figure 52. Tissue Sealing Agents and Hemostasis Manufacturing Cost Structure

Figure 53. Channels of Distribution (Direct Sales, and Distribution)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Hemostatic and Tissue Sealing Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemostatic Agents and Tissue Sealants Market Research Report 2025

Hemostat Powder and Tissue Sealing Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemostatic Sealants Market Research Report 2025

Hemostatic Tissue Sealants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tissue Sealer Market Research Report 2024

Surgical Hemostatic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemostatic Sealants and Hemostatic Patches Market Research Report 2025

Global Medical Topical Hemostatic Agent Market Research Report 2025

Global Fibrin Sealant Product Market Research Report 2024

Global Gelfoam Market Insights Forecast to 2030

Hemostat Powder and Hemostatic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medical Hemostatic Agents Market

Global Prefilled Hemostasis Agents Market Research Report 2024

Global Absorbable Hemostatic Agents Market Research Report 2024

Global Hemostatic Powders and Hemostatic Agents Market Research Report 2025

Hemostasis Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemostasis Diagnostic Device Market Research Report 2025

Global Fibrin Glue Hemostat Market Research Report 2024

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16G6108

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-27Q5892

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14K19926

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15N17310

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions